Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05039073
Title Brentuximab Vedotin and Nivolumab for the Treatment of Relapsed/Refractory Classic Hodgkin Lymphoma Previously Treated With Brentuximab Vedotin or Checkpoint Inhibitors
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Emory University
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA

Facility Status City State Zip Country Details
Emory University Hospital/Winship Cancer Institute RECRUITING Atlanta Georgia 30322 United States Details
Emory Saint Joseph's Hospital RECRUITING Atlanta Georgia 30342 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field